Timing of Tracheostomy During Extracorporeal Life Support for Respiratory Support & Management of Diffuse Alveolar Hemorrhage 2/2 ANCA Associated Vasculitis
Program Release: March 26, 2021
Expiration Date: September 26, 2021
Estimated time to complete: 60 Minutes
There are no prerequisites for participation.
Adeel Abbasi, MD
Assistant Professor of Medicine and Emergency Medicine
Julia Munchel, MD
Pulmonary and Critical Care Fellow
Physicians, Physician Assistants, Residents & Fellows.
- Describe the benefits of tracheostomy in critically ill patients treated with prolonged mechanical ventilation
- Describe the benefits of tracheostomy in patients treated with extracorporeal life support for respiratory failure
- Summarize the TracMan Trial and the 2014 Update of the Cochrane Review of Early versus Late Tracheostomy for Critically Ill Patients
- Describe the current standard of care for induction of remission in severe ANCA associated vasculitis (AAV)
- Critically appraise the literature for use of plasma exchange as a rescue therapy for severe DAH 2/2 AAV
- Consider patients that may benefit from use of IVIG for induction of remission or for management of severe DAH in setting of AAV
- Discuss the risks vs. benefits of using recombinant factor VIIa for severe DAH
- Identify the potential role for ECMO in critically ill patients with DAH
Method of Participation and How to Receive CME Credit
There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives, faculty information, and CME information prior to participating in the activity.
- View the CME presentations
- Complete the CME activity evaluation at the conclusion of the activity in order to receive a credit certificate.
In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.
This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.
Faculty Disclosure/Conflict of Interest
The following planning committee members* have disclosed that they have no relevant financial relationships:
Adeel Abbasi, MD
Eric Gartman, MD*
Douglas Martin, MD*
Julia Munchel, MD
Maria Sullivan, BS*
^Speaker has indicated their presentation will include discussion of unlabeled/investigational use of a commercial product.
Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.
The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians: The Warren Alpert Medical School of Brown University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Other Healthcare Professionals: Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hours AMA PRA Category 1 Credits™. This credit is accepted by the AAPA and AANP.
- 1.00 AMA PRA Category 1 Credit™The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 AttendanceParticipants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.